Founded in 1995, Equinox Group specializes in assessing the commercial outlook for drugs to help pharmaceutical and biotechnology companies make better business decisions. We offer innovative analysis, cutting-edge forecasting techniques, and deep experience to help our clients evaluate opportunities in all therapeutic areas.

Our work is marked by:

• Strong quantitative modeling skills and established solutions to a wide range of analytical problems
• Expertise working with complex epidemiology sources (e.g., private and public patient-level data) to analyze markets and populate forecast models
• Thorough understanding of clinical and commercial success factors in more than 200 indications across all therapeutic areas
• Extensive experience interpreting and synthesizing medical literature, audit data, and primary market research in support of client goals